LEXICON PHARMACEUTICALS, INC. Impairment of Long-Lived Assets Held-for-use
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2018-03-01
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for the quarter ending 2015-12-31 was $1.25M, a 524.00% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for the quarter ending 2015-09-30 was $2.35M, a 82.07% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for the quarter ending 2015-06-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for fiscal 2017 was $0.00.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for fiscal 2015 was $3.60M, a 73.44% decline from fiscal 2014.
- LEXICON PHARMACEUTICALS, INC. impairment of long-lived assets held-for-use for fiscal 2014 was $13.54M.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 6 month as first filed | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 9 month as first filed | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | |||||
| 2015-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.60M derived: sum of 2 quarters · filed 2018-03-01 | $3.60M derived: sum of 3 quarters · filed 2018-03-01 | $3.60M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.35M derived: sum of 2 quarters · filed 2016-11-07 | $2.35M 10-Q · filed 2016-11-07 | $2.55M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $0.00 10-Q · filed 2015-08-07 | $200.00K derived: sum of 3 quarters · filed 2017-03-06 | $13.30M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-05 | $200.00K derived: sum of 2 quarters · filed 2017-03-06 | $13.30M derived: sum of 3 quarters · filed 2017-03-06 | $13.30M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2014-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $13.30M derived: sum of 2 quarters · filed 2017-03-06 | $13.30M derived: sum of 3 quarters · filed 2017-03-06 | $13.54M 10-K · filed 2017-03-06 | ||
| 2014-09-30 | $13.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $13.10M derived: sum of 2 quarters · filed 2015-11-09 | $13.34M 10-Q · filed 2015-11-09 | $13.34M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $242.00K 10-Q · filed 2015-08-07 | $242.00K derived: sum of 3 quarters · filed 2016-03-11 | $242.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-03-31 | $242.00K 10-Q · filed 2015-05-05 | $242.00K derived: sum of 2 quarters · filed 2016-03-11 | $242.00K derived: sum of 3 quarters · filed 2016-03-11 | $242.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | $0.00 10-K · filed 2016-03-11 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | $0.00 derived: sum of 3 quarters · filed 2015-03-12 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-03-12 | $0.00 derived: sum of 3 quarters · filed 2015-03-12 | $0.00 derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-12 | $0.00 derived: sum of 3 quarters · filed 2015-03-12 | $0.00 10-K · filed 2015-03-12 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | -$2.00K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | -$2.00K derived: sum of 3 quarters · filed 2014-03-07 | -$81.00K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-03 | -$2.00K derived: sum of 2 quarters · filed 2014-03-07 | -$81.00K derived: sum of 3 quarters · filed 2014-03-07 | -$65.00K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2011-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$81.00K derived: sum of 2 quarters · filed 2014-03-07 | -$65.00K derived: sum of 3 quarters · filed 2014-03-07 | $704.00K 10-K · filed 2014-03-07 | ||
| 2011-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$63.00K derived: sum of 2 quarters · filed 2012-11-07 | $706.00K 10-Q · filed 2012-11-07 | $800.00K 10-Q · filed 2011-11-01 | $1.66M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $785.00K 10-Q · filed 2012-08-02 | $800.00K 10-Q · filed 2011-08-09 | $1.74M derived: sum of 3 quarters · filed 2013-03-11 | $1.79M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-03-31 | $769.00K 10-Q · filed 2012-05-03 | $1.72M derived: sum of 2 quarters · filed 2013-03-11 | $1.77M derived: sum of 3 quarters · filed 2013-03-11 | |||
| 2010-12-31 | $951.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $1.00M derived: sum of 2 quarters · filed 2013-03-11 | $1.00M 10-K · filed 2013-03-11 | |||
| 2010-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $50.00K 10-Q · filed 2011-11-01 | ||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $436.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |